Recent developments in immunotoxin therapy

Maria Ana Ghetie, Ellen S. Vitetta

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Immunotoxin (IT) research has been ongoing for 15 years. During the past 2 years, work has focused on several areas: on improvements and developments in first- and second-generation ITs; the preparation of new immunotoxin constructs with anti-tumor activity; novel animal models for preclinical evaluation of immunotoxins; and clinical trials, which are now entering Phase II or III in humans.

Original languageEnglish (US)
Pages (from-to)707-714
Number of pages8
JournalCurrent Opinion in Immunology
Issue number5
StatePublished - 1994

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Recent developments in immunotoxin therapy'. Together they form a unique fingerprint.

Cite this